Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Horizon Therapeutics (HZNP)

Horizon Therapeutics (HZNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,086,109
  • Shares Outstanding, K 190,778
  • Annual Sales, $ 1,300 M
  • Annual Income, $ 573,020 K
  • 60-Month Beta 1.23
  • Price/Sales 8.11
  • Price/Cash Flow 15.92
  • Price/Book 4.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.30
  • Number of Estimates 5
  • High Estimate 0.38
  • Low Estimate 0.24
  • Prior Year 0.49
  • Growth Rate Est. (year over year) -38.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.01 +27.28%
on 06/12/20
59.19 -3.21%
on 07/06/20
+9.17 (+19.06%)
since 06/05/20
3-Month
30.00 +90.97%
on 04/13/20
59.19 -3.21%
on 07/06/20
+26.53 (+86.25%)
since 04/07/20
52-Week
22.69 +152.49%
on 07/08/19
59.19 -3.21%
on 07/06/20
+32.94 (+135.28%)
since 07/05/19

Most Recent Stories

More News
New Initiative Encourages the Graves' Disease Community to FOCUS on Eye Health

Today, in support of Graves' Disease Awareness Month, Horizon Therapeutics plc (Nasdaq: HZNP) and Prevent Blindness, the nation's oldest volunteer eye health organization, launched an initiative encouraging...

HZNP : 57.29 (-1.41%)
Horizon Pharma P (HZNP)

SmarTrend identified a Downtrend for Horizon Pharma P (NASDAQ:HZNP) on April 2nd, 2020 at $30.71. In approximately 3 months, Horizon Pharma P has returned 80.98% as of today's recent price of $55.58.

HZNP : 57.29 (-1.41%)
Horizon Pharma P Set to Possibly Pullback After Yesterday's Rally of 1.35%

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $52.73 to a high of $54.08. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high...

HZNP : 57.29 (-1.41%)
Horizon Pharma P Rises 1.90% on Heavy Volume: Watch For Potential Pullback

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $49.00 to a high of $49.81. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high...

HZNP : 57.29 (-1.41%)
Is Horizon Therapeutics (HZNP) Stock a Solid Choice Right Now?

Horizon Therapeutics (HZNP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

HZNP : 57.29 (-1.41%)
Horizon Pharma P Has Returned % Since SmarTrend Recommendation (HZNP)

SmarTrend identified a Downtrend for Horizon Pharma P (NASDAQ:HZNP) on April 2nd, 2020 at $30.71. In approximately 2 months, Horizon Pharma P has returned 57.05% as of today's recent price of $48.23.

HZNP : 57.29 (-1.41%)
Why Is Horizon Therapeutics (HZNP) Up 13.2% Since Last Earnings Report?

Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HZNP : 57.29 (-1.41%)
Horizon Therapeutics plc Announces Redemption of All $400 Million of Its Exchangeable Senior Notes

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it issued a notice of redemption for all $400 million of its 2.50% exchangeable senior notes due 2022. The redemption date is August 3, 2020....

HZNP : 57.29 (-1.41%)
Data Presented on KRYSTEXXA(R) (pegloticase injection) Co-Prescribed with an Immunomodulator Adds to Growing Body of Evidence for this Treatment Approach

-- Additional data presentations highlight the effect of co-therapy for KRYSTEXXA with two other commonly used immunomodulators, supporting flexible options for patients and physicians --

HZNP : 57.29 (-1.41%)
Horizon Pharma P Rises 1.42% on Heavy Volume: Watch For Potential Pullback

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $47.73 to a high of $48.94. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high...

HZNP : 57.29 (-1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade HZNP with:

Business Summary

Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. ...

See More

Key Turning Points

2nd Resistance Point 59.26
1st Resistance Point 58.28
Last Price 57.29
1st Support Level 56.75
2nd Support Level 56.21

See More

52-Week High 59.19
Last Price 57.29
Fibonacci 61.8% 45.25
Fibonacci 50% 40.94
Fibonacci 38.2% 36.63
52-Week Low 22.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar